Related references
Note: Only part of the references are listed.Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
Lisa Oestereich et al.
ANTIVIRAL RESEARCH (2014)
Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model
Sophie J. Smither et al.
ANTIVIRAL RESEARCH (2014)
Discovery of Novel Ribonucleoside Analogs with Activity against Human Immunodeficiency Virus Type 1
Michael J. Dapp et al.
JOURNAL OF VIROLOGY (2014)
Broad Spectrum Antiviral Activity of Favipiravir (T-705): Protection from Highly Lethal Inhalational Rift Valley Fever
Amy L. Caroline et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Alphavirus Mutator Variants Present Host-Specific Defects and Attenuation in Mammalian and Insect Models
Kathryn Rozen-Gagnon et al.
PLOS PATHOGENS (2014)
The Viral Polymerase Inhibitor 2′-C-Methylcytidine Inhibits Norwalk Virus Replication and Protects against Norovirus-Induced Diarrhea and Mortality in a Mouse Model
Joana Rocha-Pereira et al.
JOURNAL OF VIROLOGY (2013)
Deep Sequencing Reveals Mutagenic Effects of Ribavirin during Monotherapy of Hepatitis C Virus Genotype 1-Infected Patients
Julia Dietz et al.
JOURNAL OF VIROLOGY (2013)
The Murine Model for Hantaan Virus-Induced Lethal Disease Shows Two Distinct Paths in Viral Evolutionary Trajectory with and without Ribavirin Treatment
Dong-Hoon Chung et al.
JOURNAL OF VIROLOGY (2013)
T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
Tatiana Baranovich et al.
JOURNAL OF VIROLOGY (2013)
Influence of genome-scale RNA structure disruption on the replication of murine norovirus-similar replication kinetics in cell culture but attenuation of viral fitness in vivo
Nora McFadden et al.
NUCLEIC ACIDS RESEARCH (2013)
Extinction of Hepatitis C Virus by Ribavirin in Hepatoma Cells Involves Lethal Mutagenesis
Ana M. Ortega-Prieto et al.
PLOS ONE (2013)
The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
Zhinan Jin et al.
PLOS ONE (2013)
Favipiravir (T-705) inhibits in vitro norovirus replication
J. Rocha-Pereira et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Development of a reverse-genetics system for murine norovirus 3: long-term persistence occurs in the caecum and colon
Armando Arias et al.
JOURNAL OF GENERAL VIROLOGY (2012)
Contribution of Intra- and Interhost Dynamics to Norovirus Evolution
Rowena A. Bull et al.
JOURNAL OF VIROLOGY (2012)
Viral Quasispecies Evolution
Esteban Domingo et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
Norovirus Gastroenteritis in Immunocompromised Patients
Karin Bok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Mutagenesis-Mediated Decrease of Pathogenicity as a Feature of the Mutant Spectrum of a Viral Population
Marta Sanz-Ramos et al.
PLOS ONE (2012)
Coxsackievirus B3 mutator strains are attenuated in vivo
Nina F. Gnaedig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Antiviral Activity of a Small Molecule Deubiquitinase Inhibitor Occurs via Induction of the Unfolded Protein Response
Jeffrey W. Perry et al.
PLOS PATHOGENS (2012)
Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
Armando Arias et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
Chronic diarrhea associated with persistent norovirus excretion in patients with chronic lymphocytic leukemia: report of two cases
Todd Capizzi et al.
BMC INFECTIOUS DISEASES (2011)
Ribavirin Can Be Mutagenic for Arenaviruses
Hector Moreno et al.
JOURNAL OF VIROLOGY (2011)
Mutation of HIV-1 Genomes in a Clinical Population Treated with the Mutagenic Nucleoside KP1461
James I. Mullins et al.
PLOS ONE (2011)
Lethal mutagenesis of viruses
Celia Perales et al.
CURRENT OPINION IN VIROLOGY (2011)
Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever
Michelle Mendenhall et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
Stephanie Beaucourt et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
Rapid Evolution of Pandemic Noroviruses of the GII.4 Lineage
Rowena A. Bull et al.
PLOS PATHOGENS (2010)
A Multi-Step Process of Viral Adaptation to a Mutagenic Nucleoside Analogue by Modulation of Transition Types Leads to Extinction-Escape
Ruben Agudo et al.
PLOS PATHOGENS (2010)
Fidelity Variants of RNA Dependent RNA Polymerases Uncover an Indirect, Mutagenic Activity of Amiloride Compounds
Laura I. Levi et al.
PLOS PATHOGENS (2010)
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
Yousuke Furuta et al.
ANTIVIRAL RESEARCH (2009)
Gastrointestinal Norovirus Infection Associated With Exacerbation of Inflammatory Bowel Disease
Raheel R. Khan et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2009)
5-Azacytidine Can Induce Lethal Mutagenesis in Human Immunodeficiency Virus Type 1
Michael J. Dapp et al.
JOURNAL OF VIROLOGY (2009)
Potential Benefits of Sequential Inhibitor-Mutagen Treatments of RNA Virus Infections
Celia Perales et al.
PLOS PATHOGENS (2009)
Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus
A. Ludwig et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells
Kyeong-Ok Chang et al.
JOURNAL OF VIROLOGY (2007)
Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence
Larissa B. Thackray et al.
JOURNAL OF VIROLOGY (2007)
In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections
Brian B. Gowen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Analysis of ribavirin mutagenicity in human hepatitis C virus infection
Stephane Chevaliez et al.
JOURNAL OF VIROLOGY (2007)
Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy
Glen Lutchman et al.
GASTROENTEROLOGY (2007)
Efficacy of orally administered T-705 on lethal avian influenza a (H5N1) virus infections in mice
Robert W. Sidwell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Prolonged norovirus shedding in infants <= 6 months of age with gastroenteritis
Toshio Murata et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population
M Vignuzzi et al.
NATURE (2006)
Murine norovirus: a model system to study norovirus biology and pathogenesis
Christiane E. Wobus et al.
JOURNAL OF VIROLOGY (2006)
Mechanisms of action of ribavirin against distinct viruses
JD Graci et al.
REVIEWS IN MEDICAL VIROLOGY (2006)
Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice
Julie K. Pfeiffer et al.
PLOS PATHOGENS (2005)
Mutagenic effects of ribavirin and response to interferon/ribavirin combination therapy in chronic hepatitis C
Y Asahina et al.
JOURNAL OF HEPATOLOGY (2005)
Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence
A Grande-Pérez et al.
JOURNAL OF VIROLOGY (2005)
Mechanism of action of T-705 against influenza virus
Y Furuta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
STAT1-dependent innate immunity to a Norwalk-like virus
SM Karst et al.
SCIENCE (2003)
Molecular indetermination in the transition to error catastrophe:: Systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity
A Grande-Pérez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
In vitro and in vivo activities of anti-influenza virus compound T-705
Y Furuta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin
D Maag et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Efficient virus extinction by combinations of a mutagen and antiviral inhibitors
N Pariente et al.
JOURNAL OF VIROLOGY (2001)
The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
S Crotty et al.
NATURE MEDICINE (2000)
Response of foot-and-mouth disease virus to increased mutagenesis: Influence of viral load and fitness in loss of infectivity
S Sierra et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
